Phospho-RAC1-S71 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Phospho-RAC1-S71 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPhospho-RAC1-S71
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formataffinity purified
Size0.05 mL, 0.1 mL, 0.2 mL
Concentration1mg/ml
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionRac and Cdc42 are members of the Rho-GTPase family. In mammals, Rac exists as three isoforms, Rac1, Rac2 and Rac3, which are highly similar in sequence. Rac1 and Cdc42, the most widely studied of this group, are ubiquitously expressed. Rac2 is expressed in cells of hematopoietic origin, and Rac3, while highly expressed in brain, is also found in many other tissues. Rac and Cdc42 play key signaling roles in cytoskeletal reorganization, membrane trafficking, transcriptional regulation, cell growth and development. GTP binding stimulates the activity of Rac/Cdc42, and the hydrolysis of GTP to GDP through the protein's intrinsic GTPase activity, rendering it inactive. GTP hydrolysis is aided by GTPase activating proteins (GAPs), while exchange
ImmunogenImmunogen: A phospho specific peptide corresponding to residues surrounding S71 of human RAC1 Calculated Molecular Weight: 28kDa
Other Names[Phospho-RAC1-S71: RAC1; MGC111543; MIG5; TC-25; p21-Rac1], [RAC1; RAC1; MIG5; Rac-1; TC-25; p21-Rac1; TC25]
Gene, Accession #[RAC1], Gene ID: 5879, NCBI: P63000.1, UniProt: P63000
Catalog #MBS128344
Price$235, $350, $525
Order / More InfoPhospho-RAC1-S71 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.